| Literature DB >> 31937738 |
Ajay K Shukla1, Smita Singh1, Azhar Sheikh1, Sanjay Singh1, Girdharilal Gupta1, Ravi Daberao1.
Abstract
In order to integrate and improve eye care in noncommunicable disease (NCD) clinics, screening for diabetic retinopathy (DR) in people with diabetes mellitus (DM) was introduced in primary and secondary-level government health facilities. Initially, the project was carried out at the fixed health facilities at one district hospital (DH), two sub-district hospitals (SDH) and two community health centers (CHCs). This was combined with training of existing health care personnel, information-education-communication (IEC) campaign among patients and service providers along with the provision of essential equipment required for screening. In the revised strategy, NCD nurses were also trained for screening. Of 12,788 DM patients registered in NCD clinics, 63.8% (n = 8159) were screened for DR by trained paramedical ophthalmic assistants and the four trained NCD nurses using non-mydriatic fundus camera and teleophthalmology supported remote grading of retinopathy. DR was detected in 9.45% (n = 771) patients and sight-threatening DR (STDR) was detected in 2.35% (n = 192) in one or both eyes. Of 8,159 people screened, 55% (n = 4481) and 45% (n = 3678) were screened at CHC and mobile screening at primary health centers (PHC), respectively. DR screening in a fixed facility at CHC combined with the mobile screening at PHC level and fixed-day screening strategy provides effective coverage.Entities:
Keywords: Diabetic retinopathy; Maharashtra model; screening
Mesh:
Year: 2020 PMID: 31937738 PMCID: PMC7001180 DOI: 10.4103/ijo.IJO_1915_19
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 1.848
Figure 1Project Locations in District Wardha Maharashtra India
Coverage of DR Screening during Pilot and Revised Strategy (N=12788 Diabetics Registered in NCD Clinics)
| Fixed Facility screening (GH/SDH/CHC ) no of persons (%) | Mobile Screening (PHC/Sub Centre) No of Persons (%) | Total DR Screening No of Persons (%) | Significance | |
|---|---|---|---|---|
| Pilot Strategy | 2413 (18.87) | 0 | 2413 (18.87) | |
| Revised Strategy | 2068 (35.99) (16.17) | 3678 (64.01) (28.76) | 5746 (100.00) (44.93) | |
| Total New Screening | 4481 (54.92) (35.04) | 3678 (45.08) (28.76) | 8159 (100.00) (63.80) | |
| Repeat annual screening | 1512 (51.89) (18.53) | 1402 (48.11) (17.18) | 2914 (35.71) |
Profile of DM patients Screened for DR at CHC and PHC
| Fixed Facility Screening (GH/SDH/CHC) No. of Patients (%) ( | Mobile Screening (PHC/Sub Centre) No. of Patients (%) ( | Total Screening No. of Patients (%) ( | Significance | |
|---|---|---|---|---|
| Gender | ||||
| Male | 2669 (59.56) | 1602 (43.56) | 4271 (52.35) | |
| Female | 1812 (40.44) | 2076 (56.44) | 3888 (47.65) | |
| Age in Years | ||||
| Mean±SD | 47.11±12.02 | 56.02±11.62 | 58.13±11.92 | |
| Type of DM | ||||
| Type I | 71 (1.58) | 44 (1.20) | 115 (1.42) | |
| Type II | 4410 (98.42) | 3634 (98.80) | 8044 (98.58) | |
| Duration of DM (in Years) | ||||
| Mean±SD | 4.14±4.53 | 5.51±4.93 | 4.76±4.73 | |
| > 10 Years | 218 (4.86) | 402 (10.93) | 620 (7.60) | |
| Nature of Treatment | ||||
| Oral Drugs | 3981 (88.84) | 3374 (91.73) | 7355 (90.15) | |
| Insulin | 121 (2.70) | 102 (2.77) | 223 (2.73) | |
| Diet Exercises | 211 (4.71) | 112 (3.05) | 323 (3.96) | |
| AYUSH System | 168 (3.75) | 90 (2.45) | 258 (3.16) | |
| Control of Blood Sugar | ||||
| Controlled | 2638 (58.87) | 1176 (31.97) | 3814 (46.75) | |
| Uncontrolled | 1843 (41.13) | 2502 (68.03) | 4345 (53.25) | |
| Systemic Comorbidities | ||||
| Nephropathy | 28 (0.62) | 44 (1.20) | 72 (0.88) | |
| H/o Stroke/MI | 36 (0.80) | 94 (2.56) | 132 (1.62) | |
| Visual Status as per (WHO) classification | ||||
| Near Normal | 2950 (65.83) | 2389 (64.95) | 5339 (65.44) | |
| Visual impairment | 1034 (23.08) | 671 (18.24) | 1705 (20.90) | |
| Severe visual impairment | 294 (6.56) | 231 (6.28) | 525 (6.43) | |
| Blind | 231 (5.16) | 359 (9.80) | 590 (7.23) |
Prevalence of DR and STDR in DM patients Screened at CHC and PHC
| Screening at CHC ( | Screening at PHC ( | Total Screening ( | Significance | |
|---|---|---|---|---|
| Prevalence of DR | ||||
| Persons (in one or both eyes) | 354 (7.90) | 417 (11.34) | 771 (9.45) | |
| Eyes (in Gradable images) | 717 (8.42) | 599 (8.95) | 1316 (8.65) | |
| Grade of DR (eyes) | ||||
| Mild NPDR | 374 (4.39) | 298 (4.45) | 672 (4.42) | |
| Moderate NPDR | 277 (3.25) | 191 (2.85) | 468 (3.08) | |
| Severe NPDR | 42 (0.49) | 67 (1.00) | 109 (0.72) | |
| PDR | 24 (0.28) | 43 (0.64) | 67 (0.44) | |
| Prevalence of DME | ||||
| Persons (in one or both eyes) | 81 (1.81) | 76 (2.07) | 157 (1.92) | |
| Eyes (Gradable images) | 147 (1.73) | 141 (2.11) | 288 (1.89) | |
| Prevalence of STDR | ||||
| Persons (in one or both eyes) | 87 (1.94) | 105 (2.85) | 192 (2.35) | |
| Eyes (Gradable images) | 150 (1.76) | 181 (2.70) | 331 (2.18) |
Compliance to Referral and Management of DR Patients Screened at CHC and PHC
| Screening at CHC No. of Persons (%) ( | Screening at PHC No. of Persons (%) ( | Total Screening No. of Persons (%) ( | Significance | |
|---|---|---|---|---|
| Referred | 997 (22.25) | 828 (22.51) | 1821 (22.32) | |
| Attended Base Hospital | 618 (13.79) | 624 (16.97) | 1242 (15.22) | |
| Compliance | 61.98% | 75.36% | 68.20% | |
| Investigated at Base Hospital | ||||
| For DR | 370 (8.26) | 401 (10.90) | 771 (9.45) | |
| For Ocular co-morbidity | 179 (3.99) | 292 (7.94) | 471 (5.77) | |
| Treatment for DR | 106 (29.94) | 143 (34.29) | 249 (32.30) | |
| LASER (PRP/Grid) | 52 (14.69) | 76 (18.23) | 128 (51.41) | |
| Anti-VEGF Inj | 42 (11.86) | 56 (13.43) | 98 (39.36) | |
| LASER + anti - VEGF Inj | 12 (3.39) | 11 (2.64) | 23 (9.24) |